Zovighian Bernard J 4
4 · Edwards Lifesciences Corp · Filed May 9, 2025
Insider Transaction Report
Form 4
Zovighian Bernard J
DirectorCEO
Transactions
- Gift
Common Stock
2025-05-08−4,122→ 92,422.551 total - Gift
Common Stock
2025-05-08+4,122→ 17,076 total(indirect: By Trust) - Tax Payment
Common Stock
2025-05-07$74.92/sh−4,253$318,635→ 52,994.551 total - Award
Common Stock
2025-05-08+43,550→ 96,544.551 total - Award
Performance Rights
2025-05-08+43,550→ 43,550 totalFrom: 2028-05-08→ Common Stock (43,550 underlying) - Award
Employee Stock Option (Right to Acquire)
2025-05-08+244,400→ 244,400 totalExercise: $74.63From: 2026-05-08Exp: 2032-05-07→ Common Stock (244,400 underlying)
Holdings
- 3,605.849(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
- [F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.